Profile change history

What changed for Mecasermin?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Mecasermin identity.

32Total events
32Record additions
0Version changes
18Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 32 connected records →

Showing the latest 32 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 17, 2026.

Record added

Federal Register notice 97-10541

The Federal Register published notice 97-10541, attributed to FDA and its parent HHS department, on 1997-04-23. Its official title is “Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Mecasermin.

PeptideScanner change date
November 17, 2026
Cited source date
April 23, 1997
Evidence lane
Regulatory
Record added

Federal Register notice 98-7053

The Federal Register published notice 98-7053, attributed to FDA and its parent HHS department, on 1998-03-19. Its official title is “Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Mecasermin.

PeptideScanner change date
November 17, 2026
Cited source date
March 19, 1998
Evidence lane
Regulatory
Record added

Federal Register notice E6-12571

The Federal Register published notice E6-12571, attributed to FDA and its parent HHS department, on 2006-08-03. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; IPLEX,” and PeptideScanner's exact reviewed identity mapping connects the document to Mecasermin.

PeptideScanner change date
November 17, 2026
Cited source date
August 3, 2006
Evidence lane
Regulatory
Record added

Federal Register notice E6-9138

The Federal Register published notice E6-9138, attributed to FDA and its parent HHS department, on 2006-06-13. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; INCRELEX,” and PeptideScanner's exact reviewed identity mapping connects the document to Mecasermin.

PeptideScanner change date
November 17, 2026
Cited source date
June 13, 2006
Evidence lane
Regulatory
Record added

ClinicalTrials.gov record NCT00516386

PeptideScanner retained ClinicalTrials.gov record NCT00516386 at 2026-11-16T17:35:13.282Z. Its registry update date was 2021-11-18, and PeptideScanner's reviewed identity mapping was mecasermin.

PeptideScanner change date
November 16, 2026
Cited source date
November 18, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00571727

PeptideScanner retained ClinicalTrials.gov record NCT00571727 at 2026-11-16T17:35:13.282Z. Its registry update date was 2023-07-06, and PeptideScanner's reviewed identity mapping was mecasermin.

PeptideScanner change date
November 16, 2026
Cited source date
July 6, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00903110

PeptideScanner retained ClinicalTrials.gov record NCT00903110 at 2026-11-16T17:35:13.282Z. Its registry update date was 2026-02-06, and PeptideScanner's reviewed identity mapping was mecasermin.

PeptideScanner change date
November 16, 2026
Cited source date
February 6, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01406444

PeptideScanner retained ClinicalTrials.gov record NCT01406444 at 2026-11-16T17:35:13.282Z. Its registry update date was 2020-07-17, and PeptideScanner's reviewed identity mapping was mecasermin.

PeptideScanner change date
November 16, 2026
Cited source date
July 17, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01438086

PeptideScanner retained ClinicalTrials.gov record NCT01438086 at 2026-11-16T17:35:13.282Z. Its registry update date was 2017-03-30, and PeptideScanner's reviewed identity mapping was mecasermin.

PeptideScanner change date
November 16, 2026
Cited source date
March 30, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01446783

PeptideScanner retained ClinicalTrials.gov record NCT01446783 at 2026-11-16T17:35:13.282Z. Its registry update date was 2012-11-20, and PeptideScanner's reviewed identity mapping was mecasermin.

PeptideScanner change date
November 16, 2026
Cited source date
November 20, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01588093

PeptideScanner retained ClinicalTrials.gov record NCT01588093 at 2026-11-16T17:35:13.282Z. Its registry update date was 2012-04-30, and PeptideScanner's reviewed identity mapping was mecasermin.

PeptideScanner change date
November 16, 2026
Cited source date
April 30, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01777542

PeptideScanner retained ClinicalTrials.gov record NCT01777542 at 2026-11-16T17:35:13.282Z. Its registry update date was 2018-03-26, and PeptideScanner's reviewed identity mapping was mecasermin.

PeptideScanner change date
November 16, 2026
Cited source date
March 26, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02636270

PeptideScanner retained ClinicalTrials.gov record NCT02636270 at 2026-11-16T17:35:13.282Z. Its registry update date was 2024-02-28, and PeptideScanner's reviewed identity mapping was mecasermin.

PeptideScanner change date
November 16, 2026
Cited source date
February 28, 2024
Evidence lane
Clinical trials
Record added

USAN Council. List No. 419. New names. Mecasermin.

PubMed lists PMID 10576957 in Clinical pharmacology and therapeutics as Journal Article, with publication-date metadata of 1999-09 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 15, 2007
Evidence lane
Literature metadata
Record added

Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.

PubMed lists PMID 15777106 in Drugs in R&D as Journal Article, Review, with publication-date metadata of 2005 (year precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
October 25, 2018
Evidence lane
Literature metadata
Record added

Mecasermin Tercica.

PubMed lists PMID 16625824 in Current opinion in investigational drugs (London, England : 2000) as Journal Article, Review, with publication-date metadata of 2006-04 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 15, 2007
Evidence lane
Literature metadata
Record added

Mecasermin rinfabate.

PubMed lists PMID 17380212 in Drugs of today (Barcelona, Spain : 1998) as Journal Article, Review, with publication-date metadata of 2007-03 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
April 27, 2017
Evidence lane
Literature metadata
Record added

Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX.

PubMed lists PMID 18363546 in Expert opinion on drug metabolism & toxicology as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2008-03 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 10, 2019
Evidence lane
Literature metadata
Record added

Mecasermin.

PubMed lists PMID 18481900 in BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy as Journal Article, Review, with publication-date metadata of 2008 (year precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
March 31, 2022
Evidence lane
Literature metadata
Record added

Mecasermin (recombinant human insulin-like growth factor I).

PubMed lists PMID 19198769 in Advances in therapy as Journal Article, Review, with publication-date metadata of 2009-01-28 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 15, 2012
Evidence lane
Literature metadata
Record added

Allergic reaction to mecasermin.

PubMed lists PMID 19663134 in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology as Case Reports, Letter, with publication-date metadata of 2009-07 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
August 11, 2009
Evidence lane
Literature metadata
Record added

Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency.

PubMed lists PMID 19707272 in Therapeutics and clinical risk management as Journal Article, with publication-date metadata of 2009-08-03 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
March 10, 2022
Evidence lane
Literature metadata
Record added

Postprandial hyperglycemia corrected by IGF-I (Increlex®) in Laron syndrome.

PubMed lists PMID 22986916 in Hormone research in paediatrics as Case Reports, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2012-09-13 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 19, 2016
Evidence lane
Literature metadata
Record added

Desensitization to mecasermin in an insulin-like growth factor 1-deficient patient.

PubMed lists PMID 25843163 in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology as Case Reports, Letter, with publication-date metadata of 2015-04-03 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
May 29, 2015
Evidence lane
Literature metadata
Record added

Recombinant production of mecasermin in E. coli expression system.

PubMed lists PMID 26339260 in Research in pharmaceutical sciences as Journal Article, with publication-date metadata of 2014 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
September 30, 2020
Evidence lane
Literature metadata
Record added

Mecasermin in Insulin Receptor-Related Severe Insulin Resistance Syndromes: Case Report and Review of the Literature.

PubMed lists PMID 29695048 in International journal of molecular sciences as Case Reports, Journal Article, Review, with publication-date metadata of 2018-04-24 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
January 24, 2019
Evidence lane
Literature metadata
Record added

Cardiac examination in children with Laron syndrome undergoing mecasermin therapy.

PubMed lists PMID 29750649 in Journal of pediatric endocrinology & metabolism : JPEM as Case Reports, Journal Article, with publication-date metadata of 2018-06-27 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
February 13, 2021
Evidence lane
Literature metadata
Record added

Efficient process development for high-level production, purification, formulation, and characterization of recombinant mecasermin in Escherichia coli.

PubMed lists PMID 32692415 in Biotechnology and applied biochemistry as Journal Article, with publication-date metadata of 2020-08-07 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
September 29, 2021
Evidence lane
Literature metadata
Record added

Alterations in Stem Cell Populations in IGF-1 Deficient Pediatric Patients Subjected to Mecasermin (Increlex) Treatment.

PubMed lists PMID 36269524 in Stem cell reviews and reports as Journal Article, with publication-date metadata of 2022-10-21 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata
Record added

Mecasermin for primary insulin-like growth factor-1 deficiency.

PubMed lists PMID 36479333 in Australian prescriber as Journal Article, Review, with publication-date metadata of 2022-12-01 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
December 10, 2022
Evidence lane
Literature metadata
Record added

Mecasermin for the treatment of Rett Syndrome: a systematic review.

PubMed lists PMID 41174329 in Neurogenetics as Journal Article, Systematic Review, with publication-date metadata of 2025-11-01 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
November 5, 2026
Evidence lane
Literature metadata